Healthcare Asset Management Market – Size, Trends, Growth, Analysis, Share, Overview, Dynamics, Key Industry, Opportunities And Forecast To 2023

Report Title “Healthcare Asset Management Market Research Report – Global Forecast till 2023” covers detailed competitive outlook and systematic framework of Global Industry at a global uniform platform.

Healthcare Asset Management Market Analysis

In recent years, organizations in the healthcare sector are facing various roadblocks. This includes the need for better resource management and stringent regulatory requirements. Proper accountability and management of assets are some of the benefits associated with the implementation of healthcare asset management. It is highly beneficial for tracking surgical equipment, for patients, newborns, and personnel identification for audit trails and treatment, and inventory management.

Read more news on:

The global Healthcare Asset Management market is projected to experience a massive growth period with a CAGR of 18.2%. The report published by the Market Research Future (MRFR) team also reveals that the imperative need to increase the efficacy of available resources, concern regarding patient safety, and the rising acceptance and adoption of advanced technology in the healthcare sector is slated to drive the market growth. Additionally, increasing R&D expenditure and applied strategies like new product development by major market players are adding more fuel to the growth of the Healthcare Asset Management market.

On the flip side, concerns regarding patient safety, the high cost of installation, lackluster implementation owing to infrastructural and organizational issues, and accuracy problems with the devices are all the major factors that can cause a downfall to the market growth during the assessment period.

Healthcare Asset Management Market Segmentation

The global healthcare asset management market is classified in terms of application, product, and end-user.

By product, the market includes radiofrequency identification devices (RFID), real-time location systems (RTLS), and ultrasound & infrared tags.

The RTLS segment is further narrowed down into software, hardware, and services. The hardware segment gets divided into readers/interrogators and tags/badges.

The RFID segment is also narrowed down further into software, hardware, and services. Hardware is sub-segmented into accessories, tags, and readers/interrogators. Tags is divided into active and passive tags. The passive tags breaks down into ultra-high-frequency tags (UHF), high-frequency tags (HF), and low-frequency tags (LF).

By application, the market divides into pharmaceutical asset management and hospital asset management.

Herein, the pharmaceutical asset management includes supply chain management and drug anti-counterfeiting. Whereas, the hospital asset management segment divides into patient management, staff management, equipment tracking and management, infection control and hand hygiene compliance, and temperature and humidity monitoring.

By end-user, the market includes Laboratories, Biotechnology, Hospital/Clinic, and Pharmaceutical companies.

Healthcare Asset Management Market Regional Analysis

Analyzing the geographical segmentation of Healthcare Asset Management Market is of utmost importance to grab a better understanding of the market. The global Healthcare Asset Management market comprises major regions like Europe, the Americas, the Middle East & Africa, and the Asia-Pacific.

The Americas are projected to be the dominant market player due to the high adoption rate of advanced technologies, demand for new and innovative technologies to prevent the usage of fake drugs, and the presence of a well-rounded and established healthcare system.

The European region is believed to be the second-biggest market for healthcare asset management. Here the market growth is aided by government funding and pouring support of the healthcare sector with increasing endeavors in research and development. With the rising incidences of drug counterfeiting, there has been an inverse demand for healthcare asset management services.

Projected as the fastest-growing regional market, Asia-Pacific will be a major player in contributing to the growing percentage of the global healthcare asset management market during the review period. The lack of development of the healthcare sector, lackluster medical facilities, and the absence of technical know-how in the Middle East & Africa region will contribute to the snail-paced growth of the market.

Healthcare Asset Management Market Competitive Analysis

The key players in this market are Intelligent InSites, IBM Corporation, Sonitor Technologies, Siemens Healthineers, Infor Inc., GE Healthcare, cenTrak, Airista Flow, JADAK (a Novanta Company), Radianse, Tyco Security Products., Stanley Black & Decker, Inc., Motorola Solutions, Inc., and Ekahau, Inc.

On Feb 2019, a globally renowned multinational IT company, IBM, announced Cigna and Sentara Healthcare to have joined an all new health utility network by using blockchain. The move aims to bring-forward a broad ecosystem of healthcare-based organizations in a highly safe and secure, shared environment. This will enable organizations to share, develop, and deploy solutions using blockchain to drive digital transformation in the healthcare industry.

On August 2018, Infor Inc., a key player in the healthcare asset management landscape, announced a latest and updated version of the Enterprise Asset Management (EAM) software. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ 

Biopreservation Market 2020 Global Analysis, Key Strategies, Development Status, Emerging Technologies, Development And Regional Trends By Forecast 2023

“Biopreservation Market Size, Forecast, 2023” report provides a comprehensive analysis of the Biopreservation Industry, providing the historical and forecasted data during the forecast period from 2018-2023.

Biopreservation Market – Overview

The escalating demand for effective preservation of biological material is anticipated to motivate the Biopreservation Market. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The Biopreservation Market is poised to achieve an 11.2% CAGR in the duration of the forecast period.

The increased demand traction observed from the healthcare and food industry is expected to create considerable opportunities for the market for biopreservation. Factors such as escalating expenditure on healthcare and mounting demand for stem cell preservation is projected to fuel the advancement of the market in the forecast period.

Read more news on:

Biopreservation Market Segmental Analysis

The biopreservation market globally has been segmented on the basis of biospecimen, product, and application. Based on product, the biopreservation market has been segmented into media and equipment. By source, the biopreservation market has been segmented into biobanking, regenerative medicine, and drug discovery. The biopreservation market has been segmented by region into Europe, the Americas, Asia Pacific, the Middle East, and Africa.

Biopreservation Market Detailed Regional Analysis

The regional analysis of the biopreservation market finds that the Americas region is likely to control the global biopreservation market due to the implementation of advanced technology, growing spending on healthcare R&D, the existence of a well-established healthcare system, and growing in-house sample storage in hospitals and research institutes. Additionally, the incidence and recent merger and acquisition activities by market companies in the region is contributing to the development of the market. The European market is estimated to be the subsequent major biopreservation market. The market development in this region can be credited to the growing number of births and continuous rise in the demand for umbilical cord preservation.

Furthermore, a mounting number of sperm and egg banks are contributing to the development of the market in this region. The Asia Pacific region is anticipated to be growing swiftly in the market all through the forecast period due to the rising population in the region, escalating awareness about stem cell preservation and constant development in the healthcare sector owing to government backing. The market in the Middle East & Africa is projected to be responsible for the smallest portion of the global biopreservation market owing to a minor healthcare sector, deficiency of technical knowledge, and inadequate medical facilities.

Biopreservation Market Competitive Analysis

The expansion of a strong value chain is additionally motivating the development of the market. The vertical supplements and product tactics of the market are advancing the potential of the market players. The growth of the market is moving in a promising direction due to new product introductions or intensifying gross revenue of the players in the market. Increased conformity of market players to new customers and market trend inclinations are boosting the growth curve of the market and will persist in the forecast period. The tactical goals intended for the market are buoyed due to advantageous product differentiation carried out by market contestants. Substantial cuts in administrative costs are inducing further expansion of the market. The effective implementation of strategies is likely to stimulate the market in the coming years.

The distinguished companies in the biopreservation market are VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., Chart Industries, Thermo Fisher Scientific, Inc, BioCision., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Sigma-Aldrich Co., Princeton CryoTech, Panasonic Biomedical, Inc., Biomatrica, Inc., and Atlanta Biologicals.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Biopreservation Industry Updates:

Nov 2018 BioLife, a regenerative medicine consumables and tools firm reported sales of its biopreservation media product of $5.3 million (€4.7 million), up 79% year-on-year. Following this development, the market is considering the scaling-up of opportunities to take advantage of the sustained demand from the cell and gene therapy market, comprising of suitable M&A prospects.

Ophthalmic Lasers Market Size, Historical Analysis, Global Trends And Industry Set For Rapid Growth With Great CAGR By Forecast 2023

Based on data by Market Research Future this report on ‘Ophthalmic Lasers Market’ delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted by manufacturers who are a part of the competitive spectrum of this business domain.

Ophthalmic Lasers Market Analysis

Ophthalmic lasers have become very common in the surgical care of many eye disorders for correcting vision and repairing the damage. Ophthalmic lasers are extensively used in the treatment of a range of ophthalmic disorders such as glaucoma, diabetic retinopathy, vein occlusions, retinal holes, and retinal detachments, wild hairs on the eyelid, and rarely, in early forms of the wet type of age-related macular degeneration.

The extensive adoption of ophthalmic lasers is the major driving force behind the growth of Ophthalmic Lasers Market. Moreover, the increasing number of product approvals along with the growing prevalence of chronic ophthalmic disorders are escalating the market on the global platform.

Read more news on:

Acknowledging the enormous growth, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global ophthalmic lasers market will register over 4.6% CAGR during the forecast period (2018–2023), garnering exponential accruals.

Additional factors propelling the market growth include the growing geriatric population, chronic disorders such as diabetes that are responsible for retinal diseases and increasing prevalence of disorders related to the eye as well as contributing to the growth of the market.  Furthermore, substantial investments transpired in the development of new lasers and clinical tests foster the growth of the market.

On the other hand, factors such as the rising cost of ophthalmic procedures, the high price of ophthalmic lasers products, and lack of skilled personnel for the effective use of ophthalmic lasers products are expected to impede the growth of the market.

Nevertheless, factors that will support the growth of the market include the growing awareness towards eye care, regulatory shift in focus towards resolving unmet medical needs, technical advancement that is making the eye surgeries easier and the improving economic conditions, worldwide that is increasing the access to the quality healthcare. 

Global Ophthalmic Lasers Market – Segments

For enhanced understanding, the report has been segmented into four key dynamics. 

By ProductExcimer Lasers, Femtosecond Lasers, Selective Trabeculoplasty (SLT) Laser, and Diode Lasers among others.

By Application:  Refractive Error Correction, Diabetic Retinopathy, Glaucoma Surgery, Age-Related Macular Degeneration (AMD)Treatment, and Cataract surgery among others.

By End-userHospitals, Specialty Clinics, and Ambulatory Surgical Centers among others.

By RegionsAsia Pacific, North America, Europe, and the Rest-of-the-World. 

Ophthalmic Lasers Market – Regional Analysis

Globally, North America leads the ophthalmic lasers market owing to the large technological advancements in the region. Moreover, factors such as the increasing ophthalmic disorders along with the rising geriatric population drive the growth of the regional market.

Also, favorable reimbursement policies and government initiatives for the development of the healthcare sector is a key driving factor contributing to market growth. The growing adoption of advanced technology is providing impetus to the growth of the market.

The ophthalmic lasers market in the European region accounts for the second-largest market, globally, owing to the increasing ophthalmic surgeries in the region.   Factors such as spreading awareness about the innovative technologies and improvement in the healthcare sector with respect to infrastructure and facilities foster the growth of the regional market.

The Asia Pacific ophthalmic lasers market heading with the ever-increasing population is emerging as a profitable market, globally. Moreover, the rapidly improving economic conditions in the APAC support the growth of the regional market.

Cataract surgery is the most prevalent procedure used, worldwide. However, in developing countries such as China and India manual and sutureless small-incision cataract surgery (SICS) is preferred because of the lower costs of this procedure which further restricts the market growth in the region.

Nevertheless, the adoption of ophthalmic lasers in China and India is at a growing stage. And, soon the market is expected to capture the momentum to grow even faster. 

 The use of femtosecond lasers has ensured high efficiency along without any collateral tissue damages. The use of these lasers along with computer-controlled optical delivery systems has led to precise incisions without any damage to the surrounding tissues. 

Global Ophthalmic Lasers Market – Competitive Analysis

Highly competitive, the global ophthalmic lasers market enjoys the presence of many large and small players which makes the market to appear fragmented. Ophthalmic lasers market is no exception when it comes to adopting strategic trends, to sustain in their market position and to drive the market.

Key players operating in the market adopt the same prevailing strategic initiatives such as merger & acquisition or strategic collaboration and investing in local manufacturers in emerging economies for product developments and manufacturing activities.

Ophthalmic Lasers Market Major Players

Key players leading the global ophthalmic lasers market include Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Carl Zeiss Meditec AG, Quantel Inc., Bausch & Lomb Incorporated, Ellex Medical Lasers Limited, Topcon Corporation, Ocular Instruments, Ziemer Ophthalmic Systems AG, Nidek Co. Limited, Lumenis Ltd., Iridex Corporation, and Lightmed USA among others.

Browse Complete Report with TOC at

Ophthalmic Lasers Industry, Innovation & Related News

January 30, 2019 —- Lutronic Vision (South Korea), a subsidiary of Lutronic Corporation, a leading global manufacturer of aesthetic and medical laser systems, and related technology announced the initiation of a preclinical trial to determine the optimal setting for its R: GEN™ laser for the treatment of Dry AMD (the dry form of age-related macular degeneration).

At the conclusion of this study, Lutronic Vision will be poised to initiate clinical evaluation of the R: GEN™ laser’s ability to treat Dry AMD.

Lutronic Vision is bringing to market the world’s first laser for Selective Retina Therapy™ with Real-Time Feedback (RTF) Technology. Through this pioneering mechanism, Lutronic aims to introduce a new concept in ophthalmic retinal lasers that will ultimately lead to better vision and an improved lifestyle for patients and practitioners, worldwide.

Cerebrospinal Fluid Management Devices Market Size, Forthcoming Developments, Business Opportunities, And Future Investments 2018 To 2023

“The Latest Research Report Global Cerebrospinal Fluid Management Devices Market By 2027 provides information on Market Size, Analysis, Shares, Forecast, Emerging Technologies and Company Profiles for key Industry Participants – Market Research future”

Cerebrospinal Fluid Management Devices Market Synopsis

The data analysts at Market Research Future Reports (MRFR) have analyzed the global cerebrospinal fluid management devices market. As per the study, the global market for cerebrospinal fluid management is estimated to record a CAGR of 5.34% and holding a value of USD 2,104.66 million by the end of 2027. The increasing prevalence of neurological diseases such as Parkinson’s disease and Alzheimer’s disease is estimated to be the most significant factor driving the global cerebrospinal fluid management market 2020. Further, the increasing case of hydrocephalus and ventriculomegaly is estimated to augment the market size.

Read more news on:

Also, various public and private companies are implementing various innovative technologies in the development of medical devices’ cerebrospinal fluid management. The established key players adopt tactics like these are estimated to grow the cerebrospinal fluid management devices market in the forthcoming period. In addition, the burgeoning technological development in the field of smart devices, along with the usage of AI and IoT, is another pivotal factor augmenting the market. Further, the rise in geriatric population is estimated to augment the market at the global front.

However, lack of expertise and side-effects related to the treatment is projected to obstruct the market growth in the forthcoming period.

Cerebrospinal Fluid Management Devices Market Segmentation

The global cerebrospinal fluid management devices market can be segmented on the basis of age group, end-user, product, and region.

On the basis of age group, the global cerebrospinal fluid management can be segmented into pediatric, adult, and geriatric.

On the basis of end-user, global cerebrospinal fluid management can be segmented into ambulatory settings, hospitals, and research and academic institutes.

On the basis of product, the global cerebrospinal fluid management can be segmented into critical care products, shunts & valves, dural sealants, and others.

On the basis of region, the global cerebrospinal fluid management can be segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Cerebrospinal Fluid Management Devices Market Regional Analysis

The data experts have conducted the regional analysis of the Americas, Europe, Asia-Pacific, and the Middle East & Africa at MRFR. As per the study, the global market is estimated to be dominated by the Americas. The region is excelling due to the presence of established key players. Besides, the region comprises of advanced healthcare infrastructure. Also, increasing awareness is estimated to expand the regional market. Europe is estimated to acquire the second position. The region has been witnessing a rise in chronic illness due to a change in lifestyle. Besides, the increasing support of the government is likely to affect the regional market positively. Also, the presence of established players in the region is likely to affect the market positively.

On the other hand, the APAC is estimated to take the third position. However, the APAC market is estimated to expand at the fastest pace due to the rising purchasing power. Also, increasing research and development is further likely to augment the market. The MEA region is estimated to acquire a substantial portion during the forecast period owing to the increasing R&D and the growing medical tourism. Besides, the increasing contribution of the government is further estimated to propel the regional market.

Cerebrospinal Fluid Management Devices Market Key Players

The Prominent Players in the Global Cerebrospinal Fluid Management Devices Market are Medtronic Plc (Ireland), Natus Medical Incorporated (US), B. Braun Melsungen AG (Germany), Sophia (France), IRRAS AB (Sweden), Möller Medical GmbH (Germany), Argi Grup (Turkey), Longeviti (US), Integra Lifesciences Corporation (US), and others.

Cerebrospinal Fluid Management Devices Industry News

June 2020: CereVasc, a US medical device company, has raised USD 43.9 million to help launch first-in-human clinical testing for invasive hydrocephalus procedure. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Medical Imaging Software Market To Expand At 8.4% CAGR From 2018 To 2023

Market Research Future (MRFR) has Thoroughly Studied the Trends and Patterns in the Global Medical Imaging Software Market. The Report offers insights into the Leading Market Players and Presents an Assessment of their Current Market Position.

Medical Imaging Software Market Insight

The global medical imaging software market is expected to exhibit a strong 8.4% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global medical imaging software market is set to exhibit a robust growth rate over the forecast period due to the growing demand for sophisticated and capable medical imaging software and the growing use of medical imaging in diagnostic and surgical procedures. The report presents a detailed breakdown of the major factors affecting the global medical imaging software market’s growth positively as well as negatively, providing the readers with a comprehensive overview of the global medical imaging software market’s economic environment and major drivers and restraints. The major players operating in the global medical imaging software market are also profiled in the report with the help of detailed competitive profiles, providing the readers with a complete overview of the competitive landscape of the market.

Read more news on:

The medical imaging software market has exhibited robust growth over the last few years due to the growing demand for medical imaging in diagnostic procedures. The dentistry sector has emerged as a major end user of diagnostic imaging devices in the last few years, with the growing demand for oral procedures leading to a growing demand for diagnostic imaging devices. The increasing availability of advanced, highly sophisticated imaging techniques for dental diagnosis and surgeries is likely to remain a key driver for the medical imaging devices market over the forecast period.

The increasing demand for minimally invasive surgeries is also likely to be a major driver for the global medical imaging software market over the forecast period. Minimally invasive surgeries are surgeries that minimize the need for cutting up and opening up a patient’s body and instead rely on superior imaging tools to acquire a picture of the area being operated. This is likely to remain a key driver for the medical imaging software market over the forecast period.

Medical Imaging Software Market Competitive Analysis:

Leading players in the global medical imaging software market include IBM Corporation, Fujifilm Holding Company, Acuo Technologies, ScienceSoft USA Corporation, Merge Healthcare Inc., MIM Software Inc., AQUILAB, Media Cybernetics Inc., Pie Medical Imaging, Hologic Inc., Agfa-Gevaert N.V., Siemens Healthineers, and GE Healthcare. Leading players in the global medical imaging software market are likely to focus on product development in the coming years, as there is significant scope in the market for major product advancements providing a significant update in terms of technology and capability.

In September 2019, Richardson Healthcare announced CE Mark approval for its ALTA750 X-ray tube.

Medical Imaging Software Market Segmentation:

The global medical imaging software market has been segmented by software type, imaging type, modality, application, end use, and region.

By software type, the global medical imaging software market is segmented into integrated and standalone software.

By imaging type, the global medical imaging software market is segmented into 2D imaging, 3D imaging, and 4D imaging.

By modality, the global medical imaging software market is segmented into computed tomography (CT), magnetic resonance imaging (MRI), radiography, photoacoustic imaging, nuclear medicine, echocardiography, ultrasound, thermography, and others.

By application, the global medical imaging software market is segmented into neurology, oncology, cardiology, musculoskeletal, obstetrics and gynecology, dental, urology and nephrology, and others.

By end use, the global medical imaging software market is segmented into clinics and hospitals, diagnostic centers, research laboratories, and others.

Obtain Premium Research Report Details @

Medical Imaging Software Market Regional Analysis:

The Americas is the dominant regional market for medical imaging software, followed by Europe. The strong presence of medical device manufacturers in North America and Europe is majorly responsible for this breakdown, as this leads to easier and widespread availability of the latest product and technology advancements. Increasing availability of venture funding and the rising expenditure on the healthcare sector are also likely to be major drivers for the medical imaging software market in the Americas. Asia Pacific is expected to be the fastest growing market for medical imaging software due to the strong growth prospects of the healthcare sector in the region.

Radiology Services Market Size, Sales, Growth Drivers, Opportunities, Industry Trends And Forecast To 2024

MRFR is the Leading Brand in The Research Company Who Recently Published Global Radiology Services Market Research Reports which includes Market Size, growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Trends and Forecast to 2024

Radiology Services Market Overview

Global radiology services market is growing dramatically, mainly due to the advances in radiology technologies. Rising usages of radiology services such as X-Rays, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, fusion imaging, and nuclear medicine, to offer accurate diagnosis are fostering the growth of the market. Additionally, factors such as the rising prevalence of chronic disease and demand for minimally invasive procedures are accelerating market growth.

According to Market Research Future (MRFR), in 2018, the global radiology services market had touched a valuation of USD 8,102.51 MN, which is projected to appreciate further at 10.5% CAGR during the forecast period (2019–2024). Increasing healthcare expenditure and the emergence of thin client 3D viewers are expected to drive the growth of the market exponentially. Moreover, rising R&D investments and strategies adopted by the top players operating in the market are contributing to the market growth, bringing about innovations and new product launches.

Read more news on:

Increasing efforts of regulatory agencies to reduce the regulatory burden on the medical device industry is further supporting the market growth excellently. For instance, in June 2018, the FDA reclassified some types of radiology image software analyzers from class III to class II devices for radiograph lung nodules, mammography breast cancer, and ultrasound breast lesions. Moreover, government initiatives to promote radiology technology as the best option for early diagnosis in the multitude of chronic daises propel the growth of the market.

On the other hand, risks associated with high radiation exposure could hamper market growth during the assessment period. Nevertheless, the availability of advanced radiology technologies would support the market growth throughout the review period, providing ample scope of the growth opportunities. Also, substantial R&D investments to bring about more novelty and betterments in imaging techniques are anticipated to boost the market growth profoundly.

Radiology Services Market – Segments

The Radiology Services Market Analysis is segmented into five main dynamics to widen the scope of understanding,

By Product Type    : Stationary Digital Radiology Systems (stationary ceiling-mounted and floor-to-ceiling mounted system) and Portable Digital Radiology Systems.

By Application       : Chest Imaging, Cardiovascular Imaging, Dental Imaging, Orthopedic Imaging, Mammography Imaging, and others.

By Technology       : Computed Radiology, Direct Digital Radiology, and others.

By End User            : Hospitals, Diagnostic Centers, and others.

By Regions              : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World

Based on the product type, the market is segmented into stationary digital and portable digital radiology systems. Out of these, the stationary digital radiology segment accounts for a substantial market share, owing to the widespread application of stationary systems in hospitals to minimize harmful radiation exposure. On the other hand, the portable digital radiology segment is growing at the highest CAGR as the low-cost, lightweight, portable devices can offer exceptional care, especially in the ICUs, emergency departments, and neonatal intensive care units (NICU) due to their capability of performing complex computational tasks. 

Global Radiology Services Market – Geographical Analysis

North America dominates the global radiology services market with the rising funding & investments made in advancing healthcare infrastructures by the governments and private entities. Besides, factors such as the increasing prevalence of chronic diseases, alongside the rising geriatric population, drive the regional market growth, creating a large patient pool.

Undoubtedly, advances in radiology technology and well-spread awareness among the population are the two major driving forces leading the growth in the radiology services market in North America. Also, the US radiology services market, heading with substantial healthcare expenditures, supports the regional market majorly.

Europe stands second in the global radiology services market owing to the increasing number of cancer patients in the region. Additionally, government funding and support to develop the healthcare sector and to drive R&D in the radiology field impact the market growth positively. Moreover, factors such as favorable reimbursement policies, the proliferation of advanced treatment facilities, and the availability of skilled medical professionals in the region are contributing to the growth of the European radiology services market.

The Asia Pacific region is emerging as a promising market for radiology services. The increasing prevalence of cancer and rising investments & expansions by the global market players are substantiating the growth of the regional market. Besides, factors such as spreading awareness among people and the availability of radiology services in the region foster the growth of the market. 

Radiology Services Market – Competitive Landscape

Fiercely competitive, the radiology services market appears highly fragmented due to the presence of many large & small-scale players. These players invest substantially to form strategic partnerships and collaborations to gain a larger competitive advantage. They also invest in driving RD activities and in meeting their expansion plans. Through R&D, they drive technology launch, and to expand their global footprints, they acquire promising companies from emerging regions. 

Radiology Services Market Major Players:

Players leading the global radiology services market include Cybernet Medical Corporation, 4ways Healthcare Limited, Everlight Radiology, Medica Reporting Ltd., Global Diagnostics, Onrad, Inc., RamSoft Inc., Radisphere National Radiology Group Inc., Siemens Healthcare, Telemedicine Clinic, Telediagnostics Services Pvt. Ltd., Virtual Radiology (vRAD), and Teleradiology Solutions Inc., among others. 

Obtain Premium Research Report Details @

Radiology Services Industry/ Innovation/Related News:

December 19, 2019 —- Fujifilm (Japan), a leading global diagnostic imaging and information systems company, announced the acquisition of a Japanese Hitachi Diagnostic Imaging Business. The deal valuing at approximately USD 1.6 BN will enable these two radiology companies to bring about a new entity that could compete with larger organizations to capture an expanded footprint & market share. This move aligns with Fujifilm’s ongoing efforts to expand its medical systems business, including platforms medical & nursing data, and new AI & analytics services. 

ICP-OES Spectrometer Market 2020 Latest Innovations, Analysis By Key Manufacturers, Commercial Sector, Overview, Component, Industry Revenue And Forecast 2025

Market Research Future recently published ICP-OES Spectrometer Market Research Report – Global Forecast till 2025, Concentrates On Restraints, Reimbursement Policies, Technological Advancements, competitive outlook

ICP-OES Spectrometer Market Analysis  

Global ICP-OES spectrometer market was valued at USD 521.4 million in 2018 and is likely to grow at a 7.2% CAGR between 2019- 2025, according to the new report by Market Research Future (MRFR). ICP-OES (inductively coupled plasma optical emission spectroscopy) spectrometer, simply put, is an analytical method that is used to detect chemical elements. This instrument uses the ICP-OES to conduct the analysis procedure. Simultaneous and sequential are the two types of ICP-OES spectrometer.  

Various factors are propelling the global ICP-OES spectrometer market growth. As per the latest MRFR report, such factors include growing technological advances, the development of better analytical systems, and increasing research and development expenditure.  

Read more news on:

On the contrary, the need for huge capital investment to set up instrument manufacturing plants and the soaring price of instruments are factors that may impede the global ICP-OES spectrometer market growth over the forecast period. Besides, the grave effect of the ongoing COVID-19 pandemic is also impacting the market growth. 

ICP-OES Spectrometer Market Key Players 

Eminent players profiled in the global ICP-OES spectrometer market report include Merck KGaA (Germany), Hitachi High-Technologies Corporation (Japan), FPI (China), Beijing Huake Tiancheng Technology Co., Ltd (China), Skyray Instrument Inc. (US), Horiba (Japan), Analytik Jena AG (Germany), Teledyne Leeman Labs (US), SPECTRO Analytical Instruments GmbH (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific (US), GBC Scientific Equipment (Australia), Shimadzu Corporation (Japan), and PerkinElmer Inc. (US), among others. 

ICP-OES Spectrometer Market Segmentation 

The MRFR report provides an inclusive segmental analysis of the global ICP-OES spectrometer market report based on end user, application, and spectrometer type.  

By spectrometer type, the global ICP-OES spectrometer marketis segmented into simultaneous and sequential. Of these, the sequential segment will lead the market over the forecast period for its wider availability. Meanwhile, the simultaneous segment is likely to grow at a fast pace for its increasing adoption rate.  

By application, the global ICP-OES spectrometer market is segmented into food and agriculture, environmental testing, drug discovery, nanotechnology, and others. Of these, drug discovery will dominate the market over the forecast period for its extensive application. Meanwhile, environmental testing will grow at a fast pace over the forecast period for the rising number of research activities that use this spectrometer for the purpose of environmental testing.  

By end user, the global ICP-OES spectrometer market is segmented into research and academic institutes, pharmaceutical & biotechnology companies, and others. Among these, pharmaceutical & biotechnology companies will have a major share in the market over the forecast period for its growing application in the pharmaceutical sector. Meanwhile, the research and academic institutes will grow at a fast pace over the forecast period for the surging research activities.  

ICP-OES Spectrometer Market Regional Analysis  

Based on the region, the global ICP-OES spectrometer market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa. Of these, the Americas will have the lions share in the market over the forecast period. The presence of top companies, growing adoption of new technology, and increasing investment on research and development to create new technologies are adding to the global ICP-OES spectrometer market growth in the region.  

The global ICP-OES spectrometer market in Europe is predicted to hold the second-largest share over the forecast period. Increasing use of this spectrometer for various research needs coupled with the presence of a well-developed healthcare system are adding to the ICP-OES spectrometer market growth in the region.  

The global ICP-OES spectrometer market in the APAC region is predicted to grow at a fast pace over the forecast period. The booming pharmaceutical industry in Japan, India, and China is adding to the ICP-OES spectrometer market growth in the region.  

The global ICP-OES spectrometer market in the Middle East & Africa is likely to hold the smallest share during the forecast period for the region’s low disposable income. Besides, the presence of eminent players in the region is also limited, which again is likely to hamper the market growth in the future. 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ 

Patient Lift Slings Market 2020 Global Recent Trends, Competitive Landscape, Size, Segments, Emerging Technologies And Industry Growth By Forecast To 2025

Report Title “Patient Lift Slings Market Research Report – Global Forecast till 2025” covers detailed competitive outlook and systematic framework of Global Industry at a global uniform platform.

Patient Lift Slings Market Overview

Expanding pervasiveness of incessant issue requiring long haul patient consideration is foreseen to help the utilization of restorative lifting slings.

Geriatric populace shapes the objective populace for this market. This statistic is exceptionally inclined to age-related issue, which in specific cases causes stability in patients. In addition, the coming of old consideration focuses and long haul care focuses, restrictive for geriatric patients opens up roads for market players.

Read more news on:

Home medicinal services is a monetary alternative over emergency clinics, where post-usable recuperation and long haul care can be benefited effectively through hospices or expert home social insurance administrations. Multiplication of these administrations gives business chances to market members to strategically pitch the items other than customary settings. The quickly developing demand for social insurance administrations is credited to the developing workforce in this field, which is relied upon to serve this market as a driver. Innovative technologies in therapeutic lifting slings rendered the patient lifting process proficient because of less wounds and disasters during the procedure. For example, use of water powered innovation in patient lifting builds the solace level for patients and lessens the additional endeavors required by the staff. Thus, mechanical progressions in this vertical are helping the market to develop quickly.

The administration alongside social insurance affiliations is endeavoring to bring down medicinal services costs. Home social insurance administrations are developing quickly as these administrations offer effective long haul patient consideration at a lower cost. Utilization of all patient taking care of hardware including patient lifting slings is advanced in these settings. Subsequently, the development of home social insurance is applying a significant effect on the market elements.

Patient Lift Slings Market Competitive Analysis:

The key players operating in the global patient lift slings market include Getinge Group (ArjoHuntleigh), Hill-Rom, Invacare Corporation, Joerns Healthcare LLC, Prism Medical, Argo Medical, Inc., DJO Global, -Spectra Care Group, and V.Guldmann A/S.

Patient Lift Slings Market Segmentation:

The patient lift slings market is segmented based on product, sling shape, sling materials, usage, end user, and region.

In terms of product, the global patient lift slings marketis categorized into bariatric slings, seating slings, stand up sling, bathing & toileting slings, and other.

Based on the sling shape, the market is segmented into full body sling and U-shape.

Based on the sling material, the market is segmented into mesh, padded, nylon, polyester, and others.

Based on the usage, the market is segmented into reusable and disposable.

Based on the end user, the market is segmented into hospitals, home care settings, and others.

Patient Lift Slings Market Regional Analysis:

Based on the region, the market is segmented into Europe, the Americas, Asia Pacific, and the Middle East & Africa. Of these, the Europe are estimated hold strong position in the patient lift slings market owing to inferable from higher research costs and activities gives propelled gadgets and private-open organizations, and consequently held the most extreme offer in this vertical. What’s more, pervasive constant illnesses and the presentation of strong repayment plans are the fundamental components overseeing the development of the vertical in this locale. However, Asia Pacific is foreseen to observe a quick development rate over the conjecture time frame. Expanding per capita salary and financial improvement and the nearness of high neglected needs of the enormous populace pool in this locale is relied upon to contribute toward huge development.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Mixed Reality in Healthcare Market – Positive Outlook For Industry Opportunities & Trends For Expansion In 2020

Market Research Future published a half-Cooked research report on “Global Mixed Reality in Healthcare Market Research Report, forecast to 2024” – Market Size, Share, Growth, Analysis, Regional Outlook, Scope, Stake, Progress, Trends.

Mixed Reality in Healthcare Market Outlook

Mixed reality (MR) is a blend of digital and physical content and distinct from its counterparts, virtual and augmented reality. It is also known as hybrid reality. The application of mixed reality in the healthcare sector in aiding doctors, clinicians, and surgeons in diagnosis and improving outcomes of patients can widen its scope vastly. The virtual content will be displayed in the form of videos or 3D models. The global mixed reality in healthcare market report by Market Research Future (MRFR) delineates the various factors, drivers, and challenges in a detailed and comprehensive manner.

The global mixed reality in healthcare market size is predicted to touch USD 2,475 million by 2024. It can exhibit 26.3% CAGR from 2019 to 2024 (forecast period). Transition towards digitization of various processes is one of the primary drivers of the market. Development of sensors and headsets, application in patient care and disease management, and mass acceptance by users can drive the market growth till the end of the forecast period.

Read more news on:

Advancements in user interfaces and haptic technology as well as their application in assisting doctors, surgeons, and support staff can be a strong market driver. Benefits of MR which can alleviate doctor workloads and improve service quality can bode well for the mixed reality in healthcare market. According to a randomized controlled trial by Samsung Corporation, virtual reality (VR) therapy can reduce pain levels by 52%.

However, paucity of skilled personnel, high cases of technical glitches, and heavy investment costs can hamper market growth.

Mixed Reality in Healthcare Market Segmentation Analysis

The global mixed reality in healthcare market growth is segmented by component, device type, application, and end-user.

By component, it is segmented into hardware, software, and service. The software segment had accounted for a large market share due to accessibility of the MR software to users for early testing. On the other hand, the hardware segment is expected to grow at a rapid pace during the forecast period.

By device type, it is segmented into augmented reality (AR) in healthcare and virtual reality (VR) in healthcare. The AR in healthcare segment can hold a major market share due to application of AR for alleviating pain levels. On the flip side, the VR in healthcare segment can expand at a robust growth rate due to rising awareness as well as backed up research.

By application, it is segmented into fitness management, patient management, pharmacy management, surgery, surgery simulation, and others. The surgery simulation segment can capture a large share of the mixed reality in healthcare market due to the use of the setup in training upcoming medical students in new surgical techniques.

By end-user, it is segmented into research organizations, hospitals & surgical centers, and others. Hospitals & surgical centers can command the lion’s share of the market due to the rising number of hospitals adopting MR technology.

Mixed Reality in Healthcare Market Regional Analysis

The Middle East & Africa, Latin America, Asia Pacific (APAC), North America, and Europe are regions taken into consideration in the compilation of the global mixed reality in healthcare market report.

The Americas is expected to be the leading region in the global market due to adoption of MR software and increased healthcare budget of the countries. The use of MR in minimally invasive procedures for improving surgical outcomes can lead to significant revenue generation.

The APAC region is projected to exhibit a stupendous growth rate due to a large patient pool and changing government reforms pertaining to healthcare. The region can accrue significant revenue due to increasing collaborations between medtech companies and hospitals.

Mixed Reality in Healthcare Market Competitive Analysis

Major industry participants in the global mixed reality in healthcare market include Echopixel, Medical Realities, Mindmaze, Surgical Theatre LLC, Psious, Osso VR, Atheer, Orca Health, Daqri, Samsung Electronics, Microsoft, Oculus VR, Augmedix, Firsthand Technology, and Google. Development of innovation pilots by companies as well as constant upgrade of the software are certain steps taken to improve their standings in the market.

Mixed Reality in Healthcare Industry News

Microsoft and Philips have decided to collaborate for expanding the application of mixed reality for the Holo Lens 2 headset, the brainchild of Microsoft. The amalgamation of VR and AR can be used in understanding the human condition as well as extend its application beyond pain management.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Cardiac Biomarkers Market: Latest Trends, Growth, And Profitability

“Cardiac Biomarkers Market Size, Forecast, 2025” report provides a comprehensive analysis of the Cardiac Biomarkers Industry, providing the historical and forecasted data during the forecast period from 2019-2025.

Cardiac Biomarkers Market Overview

Cardiac biomarkers are often referred to as cardiac markers. The cardiac biomarkers (endogens, including enzymes, hormones, and proteins) are released into the blood if the heart is damaged or stressed. Generally, they are used to treat heart attack and acute coronary syndrome (ACS) or disorders associated with insufficient blood flow to the core

According to Market Research Future (MRFR), Cardiac Biomarkers Market is expected to cross USD 4236.02 Million 2025 at a CAGR of 16.36by 2025 (forecast period). The research report serves as insight and knowledge repository for all market aspects including, regional markets, technology, types, and applications. 

Read more news on:

Cardiac Biomarkers Market Dynamics

There are a variety of factors that affect the development of the demand for cardiac biomarkers. Some of the main factors include growing demand for the diagnosis and testing of various cardiovascular diseases, the production and advancement of cardiac biomarkers and the growth of the patient population suffering from cardiovascular disease. Other primary growth factors include a rise in the number of new cardiovascular cases diagnosed per year and an increase in demand for disease-specific care in which cardiac biomarkers are used. Increased prevalence of the cardiovascular disease is projected to fuel the demand for cardiac biomarkers during the forecast period. Approximately 17.7 million people die each year from cardiovascular diseases (CVDs), according to the World Health Organization, and it is estimated to be the cause of 31% of the total deaths worldwide. About 80% of all deaths from CVDs are attributed to heart attacks and strokes. Nonetheless, the demand for cardiac biomarkers is experiencing constraints due to the emergence of other methods for cardiovascular disease diagnosis, along with high procedural costs, lack of full proof assurance, and strong competition among existing players. 

Cardiac Biomarkers Market Segmentation 

The global cardiac biomarkers market size can be classified based on type, location of testing, application, and region.

Based on type, the cardiac biomarkers market can be segmented into Myocardial muscle Creatine Kinase (CK-MB), troponins (T and I), myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, ischemia-modified albumin (IMA), and others. Owing to its prodigious sensitivity and ability to reliably diagnose the heart events of an acute coronary syndrome (ACS), Troponins I and T are the leading revenue-generating segment in the global cardiac biomarkers market.

The location of testing is further segmented into point of care testing and laboratory testing. The point of care testing is projected to see steady growth in the forecast period due to its increasing popularity. The laboratory testing segment dominated the global market for cardiac biomarkers. Increased demand for cardiovascular disease diagnostics is increasing the revenue of this segment.

In terms of application, the demand for cardiac biomarkers can be divided in terms of diagnosis into congestive heart failure, myocardial infarction, acute coronary syndrome, atherosclerosis, and others.

Regionally, the cardiac biomarkers market can be classified into five regional markets, such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe dominate the global market for cardiac biomarkers due to an increasing population of patients suffering from cardiovascular disease (angina pectoris, myocardial infringement, etc.), lack of physical activity, and poor diet. Europe has one of the best healthcare services in the world, and the increasing participation of market players is boosting the European market for cardiac biomarkers. For example, in October 2019, Novartis received FDA approval for Entresto for the treatment of symptomatic heart failure in pediatric patients aged one year and older. The Middle East and Africa have mainly been divided into two regions: The Middle East and Africa. The presence of favourable government initiatives and recent health reforms and the development of healthcare infrastructure in the Middle East is expected to increase market growth over the forecast period. Moreover, India, Southeast Asia, and China are evolving markets for cardiac biomarkers due to an increased incidence of coronary artery disease in these regions. Initiatives by the Government of Asia-Pacific towards the development of health care infrastructure are also expected to boost the growth of the market for cardiac biomarkers in the region. 

Cardiac Biomarkers Market Key Players 

Key companies operating in the global cardiac biomarkers market are Abbott Laboratories, ACS Biomarker (The Netherlands), BD (Becton, Dickinson, and Company) (US), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Hoffmann-La Roche Ltd (Switzerland), Johnson and Johnson (US), Quidel Corporation (US), Randox Laboratories Limited (UK), Siemens AG (Germany), Thermo Fisher Scientific, Inc. (the US), Trivitron Healthcare Pvt. Ltd. (India), and Novartis (Switzerland).

Obtain Premium Research Report Details, Considering the impact of COVID-19 @

Create your website at
Get started